Value proposition

Driven by our mission: More life for people with cancer.

We do not just develop and deliver innovative medicines. We bring together ambitious, collaborative and courageous people who are committed to finding ways to treat cancer differently.

MorphoSys began as a research and development technology provider 30 years ago, which positioned us as a valuable partner to pharmaceutical manufacturers worldwide. This empowered our evolution into a fully integrated biopharmaceutical company, and our growth over the past 15 years can only be attributed to the dedicated and passionate people driving our mission forward: More life for people with cancer.

For additional information on our community guidelines, please visit https://www.morphosys.com/en/community-guidelines

Cancer, Inflammation, Biologics, Antibodies, Biotechnology, and Epigenetics